MicroRNA-152 targets ADAM17 to suppress NSCLC progression

FEBS Letters

Volumn 588, Issue 10, 2014, Pages 1983-1988

  Su, Yunshu ^a   Wang, Yuchang ^a   Zhou, Hongmin ^a   Lei, Lei ^a   Xu, Lijun ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

ADAM metallopeptidase domain 17; Invasion; Migration; miR 152; Non small cell lung cancer; Proliferation

Indexed keywords

MESSENGER RNA; MICRORNA; MICRORNA 152; UNCLASSIFIED DRUG;

ADAM17 GENE; ARTICLE; BINDING SITE; CANCER CELL CULTURE; CANCER INHIBITION; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CLINICAL ARTICLE; COLONY FORMATION; CONTROLLED STUDY; DOWN REGULATION; GENE OVEREXPRESSION; GENE SILENCING; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; PRIORITY JOURNAL; TUMOR GENE;

ADAM METALLOPEPTIDASE DOMAIN 17; INVASION; MIGRATION; MIR-152; NON-SMALL CELL LUNG CANCER; PROLIFERATION;

3' UNTRANSLATED REGIONS; ADAM PROTEINS; BASE SEQUENCE; BLOTTING, WESTERN; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DISEASE PROGRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HEK293 CELLS; HUMANS; LUCIFERASES; LUNG NEOPLASMS; MICRORNAS; MUTATION; NEOPLASM INVASIVENESS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TUMOR STEM CELL ASSAY;

EID: 84900392612     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1016/j.febslet.2014.04.022     Document Type: Article

References (23)

1. R. Siegel, D. Naishadham, and A. Jemal Cancer statistics, 2012 CA Cancer J. Clin. 62 2012 10 29
2. H. Nakamura, Y. Taniguchi, K. Miwa, Y. Adachi, S. Fujioka, T. Haruki, Y. Takagi, and Y. Yurugi Comparison of the surgical outcomes of thoracoscopic lobectomy, segmentectomy, and wedge resection for clinical stage I non-small cell lung cancer Thorac. Cardiovasc. Surg. 59 2011 137 141
3. B. Aryal, N. Rotllan, and C. Fernandez-Hernando Noncoding RNAs and atherosclerosis Curr. Atheroscler. Rep. 16 2014 407
4. C. Xin, H. Zhang, and Z. Liu MiR-154 suppresses colorectal cancer cell growth and motility by targeting TLR2 Mol. Cell. Biochem. 387 2014 271 277
5. N. Kolesnikoff, J.L. Attema, S. Roslan, A.G. Bert, Q.P. Schwarz, P.A. Gregory, and G.J. Goodall Specificity protein 1 (Sp1) maintains basal epithelial expression of the miR-200 family: implications for epithelial-mesenchymal transition J. Biol. Chem. 289 2014 11194 11205 10.1074/jbc.M113.529172
6. H. Yang, Q. Li, W. Zhao, D. Yuan, H. Zhao, and Y. Zhou MiR-329 suppresses the growth and motility of neuroblastoma by targeting KDM1A FEBS Lett. 588 2014 192 197
7. Y. Ke, W. Zhao, J. Xiong, and R. Cao Downregulation of miR-16 promotes growth and motility by targeting HDGF in non-small cell lung cancer cells FEBS Lett. 587 2013 3153 3157
8. X. Wang, H. Yu, X. Lu, P. Zhang, M. Wang, and Y. Hu MiR-22 suppresses the proliferation and invasion of gastric cancer cells by inhibiting CD151 Biochem. Biophys. Res. Commun. 445 2014 175 179
9. L. Lei, Y. Huang, and W. Gong MiR-205 promotes the growth, metastasis and chemoresistance of NSCLC cells by targeting PTEN Oncol. Rep. 30 2013 2897 2902
10. L. Wan, L. Zhang, K. Fan, and J. Wang MiR-27b targets LIMK1 to inhibit growth and invasion of NSCLC cells Mol. Cell. Biochem. 390 2014 85 91 10.1007/s11010-013-1959-1
11. X. Zheng, M. Chopp, Y. Lu, B. Buller, and F. Jiang MiR-15b and miR-152 reduce glioma cell invasion and angiogenesis via NRP-2 and MMP-3 Cancer Lett. 329 2013 146 154
12. T. Tsuruta et al. MiR-152 is a tumor suppressor microRNA that is silenced by DNA hypermethylation in endometrial cancer Cancer Res. 71 2011 6450 6462
13. C. Sanfiorenzo, M.I. Ilie, A. Belaid, F. Barlesi, J. Mouroux, C.H. Marquette, P. Brest, and P. Hofman Two panels of plasma microRNAs as non-invasive biomarkers for prediction of recurrence in resectable NSCLC PLoS One 8 2013 e54596
14. J. Huang, Y. Wang, Y. Guo, and S. Sun Down-regulated microRNA-152 induces aberrant DNA methylation in hepatitis B virus-related hepatocellular carcinoma by targeting DNA methyltransferase 1 Hepatology 52 2010 60 70
15. M. Azizi, L. Teimoori-Toolabi, M.K. Arzanani, K. Azadmanesh, P. Fard-Esfahani, and S. Zeinali MicroRNA-148b and microRNA-152 reactivate tumor suppressor genes through suppression of DNA methyltransferase-1 gene in pancreatic cancer cell lines Cancer Biol. Ther. 15 2014
16. C. Zhu et al. MiR-152 controls migration and invasive potential by targeting TGFalpha in prostate cancer cell lines Prostate 73 2013 1082 1089
17. P. Primakoff, and D.G. Myles The ADAM gene family: surface proteins with adhesion and protease activity Trends Genet. 16 2000 83 87
18. X. Ding, L.Y. Yang, G.W. Huang, W. Wang, and W.Q. Lu ADAM17 mRNA expression and pathological features of hepatocellular carcinoma World J. Gastroenterol. 10 2004 2735 2739
19. T. Yoshimura, T. Tomita, M.F. Dixon, A.T. Axon, P.A. Robinson, and J.E. Crabtree ADAMs (a disintegrin and metalloproteinase) messenger RNA expression in Helicobacter pylori-infected, normal, and neoplastic gastric mucosa J. Infect. Dis. 185 2002 332 340
20. F. Blanchot-Jossic, A. Jarry, D. Masson, K. Bach-Ngohou, J. Paineau, M.G. Denis, C.L. Laboisse, and J.F. Mosnier Up-regulated expression of ADAM17 in human colon carcinoma: co-expression with EGFR in neoplastic and endothelial cells J. Pathol. 207 2005 156 163
21. X. Lv, Y. Li, M. Qian, C. Ma, H. Jing, Z. Wen, and D. Qian ADAM17 silencing suppresses the migration and invasion of non-small cell lung cancer Mol. Med. Rep. 9 2014 1935 1940 10.3892/mmr.2014.2029
22. X. Zheng, F. Jiang, M. Katakowski, Y. Lu, and M. Chopp ADAM17 promotes glioma cell malignant phenotype Mol. Carcinog. 51 2012 150 164
23. X. Zheng et al. Inhibition of ADAM17 reduces hypoxia-induced brain tumor cell invasiveness Cancer Sci. 98 2007 674 684